-+ 0.00%
-+ 0.00%
-+ 0.00%

TG Therapeutics Raises FY2026 Sales Guidance from $875.000M-$900.000M to $925.000M vs $906.021M Est

Benzinga·05/06/2026 11:11:41
Listen to the news
TG Therapeutics (NASDAQ:TGTX) raises FY2026 sales outlook from $875.000 million-$900.000 million to $925.000 million vs $906.021 million estimate.